By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282


SEARCH JOBS


Industry
Biotechnology






Company News
Immunomedics, Inc. (IMMU) CEO, William Hearl, Ph.D. To Speak At 2015 BIO International Convention 6/3/2015 12:39:45 PM
Immunomedics, Inc. (IMMU) Reports Labetuzumab Govitecan Is Active In Relapsed Metastatic Colorectal Cancer 6/2/2015 10:17:05 AM
Immunomedics, Inc. (IMMU) Announces Durable Responses In Metastatic Lung Cancer Patients Treated With Sacituzumab Govitecan 6/2/2015 8:38:26 AM
ASCO15: Immunomedics, Inc. (IMMU) Reports Complete Responses In Patients With Metastatic Triple-Negative Breast Cancer After Sacituzumab Govitecan Treatment 6/1/2015 10:31:15 AM
Immunomedics, Inc. (IMMU) Reports Promising Results With Sacituzumab Govitecan In Patients With Metastatic Gastrointestinal Cancers 6/1/2015 8:15:39 AM
Immunomedics, Inc. (IMMU) To Present At Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 7:06:54 AM
Immunomedics, Inc. (IMMU) Awarded Fast Track Designation By FDA For Sacituzumab Govitecan For Non-Small Cell Lung Cancer Therapy 5/15/2015 11:04:06 AM
Immunomedics, Inc. (IMMU) Awarded $1.2 Million Department Of Defense Grant For Development Of ARA-LAMP-Vax Peanut Allergy Vaccine 5/13/2015 7:49:11 AM
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Sacituzumab Govitecan To 2033 5/12/2015 7:41:34 AM
Immunomedics, Inc. (IMMU) Announces Third Quarter Fiscal 2015 Results And Clinical Program Developments 5/7/2015 8:04:34 AM
12345678910...
//-->